Life Science Compliance Update

Pharmaceutical and medical device manufacturers continue to face intense scrutiny from regulatory and enforcement agencies, as…

Part 2: The Tension Increases - Online Auctions Violate the AKS We have noted in previous articles that there is an increasing…

Part 1: An Uncertain Future in a Dynamic Landscape Fans of Star Trek will remember the scene from the 1994 movie “Generations”…

Seven states and the District of Columbia currently have regulations that limit or ban industry gifts to physicians, and it seems…

Measuring the effectiveness of compliance programs is no easy task since governing agencies have not published a template that…

At the 14th Annual CBI Pharmaceutical Compliance Congress held in April 2017, almost half the attendees were from small to…

The 21st Century Cures Act (“Act”), which provides substantial funding for medical research, seeks to alleviate the regulatory…

Allergan has been hit with hefty fines over the past several months. This article outlines Allergan's alleged wrongdoing, and the…

In constructively bringing an end to a False Claims Act (“FCA”) whistleblower suit alleging Genentech, Inc. (“Genentech”) of…

Lately pharmaceutical marketing has been under increasing attack at both state and federal governmental levels. Now Chicago has…